Tuesday, January 26, 2021

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) Secures Inclusion in Two Cannabis ETFs

 HempFusion Wellness (TSX: CBD.U), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, this morning reported that it attained inclusion in two leading cannabis and hemp-derived CBD focused exchange-traded funds (“ETFs”), AdvisorShares Pure US Cannabis ETF (NYSE: MSOS) and AdvisorShares Pure Cannabis ETF (NYSE: YOLO). YOLO, the first US-based actively managed ETF focused on the global cannabis industry, and MSOS, the only US-listed ETF dedicated solely to US cannabis exposure, intend to achieve long-term capital growth by investing in major cannabis and hemp-derived CBD companies internationally. As of January 22, 2021, the two ETFs hold combined assets under management (“AUM”) of more than $880,000,000. “We are pleased the AdvisorShares ETFs have initiated positions in our company. This represents a strong milestone for the Company and provides us added exposure to the investment community,” Jason Mitchell, N.D., HempFusion co-founder and CEO stated in the news release. “Inclusion in these ETFs brings additional exposure to potential new investors as well as generates value for existing shareholders. With our listing on the TSX, current market capitalization, and liquidity, we believe we now meet many cannabis-related ETFs’ inclusion requirements, and we look forward to other potential ETFs’ initiating positions.”

To view the full press release, visit https://ibn.fm/wyMNc

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in store or online. For more information about the company, visit www.HempFusion.com.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://ibn.fm/HempFusion 

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

No comments: